Anastasiia Gryniukova
Anastasiia is an accomplished drug discovery expert currently in the role of Senior Research Scientist in Mechanistic Biology and Profiling at AstraZeneca, based in Cambridge, United Kingdom. She drives delivery of mechanistic and safety data packages to various drug discovery programs. Complementing her scientific background, she specialises in implementing automated workflows and predictive ML models for compound profiling, while facilitating cross-functional partnerships with data scientists to advance AI integration throughout multiple programs. Anastasiia holds a Ph.D. in Bioorganic Chemistry and an Executive MBA, combining deep scientific expertise with business management capabilities. With over a decade of experience in the pharmaceutical sector, her extensive background includes managing high-throughput screening teams, developing and optimising biochemical, biophysical, and cell-based assays, and executing large-scale screening campaigns from proof-of-concept to lead optimisation stages.